Millipore Sigma Vibrant Logo

236015 COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem

The COX-2 Inhibitor V, FK3311, also referenced under CAS 116686-15-8, controls the biological activity of COX-2. This small molecule/inhibitor is primarily used for Cell Signaling applications.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide

View Products on Sigmaaldrich.com
236015
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
116686-15-8C₁₅H₁₃F₂NO₄S

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
236015-5MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA cell-permeable and orally available sulfonanilide that acts as a COX-2-selective non-steroidal anti-inflammatory drug (NSAID). Shown to exhibit 500-fold greater potency in inhibiting the LPS-induced (IC50 = 316 nM in human mononuclear cells) than the non-induced/constitutive (IC50 = 160 µM in human platelets) TxB2 production in vitro and effectively alleviate warm ischemia-reperfusion injury in the canine liver and rat lung in vivo.
      Catalogue Number236015
      Brand Family Calbiochem®
      Synonyms4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide
      References
      ReferencesOtani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.
      Product Information
      CAS number116686-15-8
      FormWhite solid
      Hill FormulaC₁₅H₁₃F₂NO₄S
      Chemical formulaC₁₅H₁₃F₂NO₄S
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      S PhraseS: 22-24/25-36/39

      Do not breathe dust.
      Avoid contact with skin and eyes.
      Wear suitable protective clothing and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      236015-5MG 04055977217155

      Documentation

      COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      COX-2 Inhibitor V, FK3311 - CAS 116686-15-8 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      236015

      Riferimenti bibliografici

      Panoramica delle referenze
      Otani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-March-2009 RFH
      Synonyms4ʹ-Acetyl-2ʹ-(2,4-Difluorophenoxy)methanesulfonanilide
      DescriptionA cell-permeable and orally available sulfonanilide that acts as a COX-2-selective non-steroidal anti-inflammatory drug (NSAID). Shown to exhibit 500-fold greater potency in inhibiting the LPS-induced (IC50 = 316 nM in human mononuclear cells) than the non-induced/constitutive (IC50 = 160 µM in human platelets) TxB2 production in vitro and effectively alleviate warm ischemia-reperfusion injury in the canine liver and rat lung in vivo.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number116686-15-8
      Chemical formulaC₁₅H₁₃F₂NO₄S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (30 mg/ml) or Ethanol (15 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesOtani, Y., et al. 2007. J. Invest. Surg. 20, 175.
      Sunose, Y., et al. 2001. Transplant Proc. 33, 862.
      Grossman, C.J., et al. 1995. Inflamm. Res. 44, 253.
      Nakamura, K., et al. 1993. Chem. Pharm. Bull. 41, 2050.
      Tsuji, K., et al. 1992. Chem. Pharm. Bull. 40, 2399.